Suchergebnisse

Background: Shared governance of employees is crucial in building trust within healthcare organizations. Control over practice, ownership of actions, feeling of independence and involvement in work decisions significantly increase employees' intent to stay, whereas exclusion from the decision-making process leads to a higher rate of turnover. Improving decision-making and enhancing collaboration among nursing staff and nurse leaders pave the way for greater autonomy and management of healthcare delivery. Purpose: The study aims to examine shared governance perceptions among Jordanian registered nurses in different clinical areas. Methods: A descriptive, cross-sectional design was used using the RN-focused index of professional nursing governance survey. A convenient sample consisting of 261 nurses was recruited from three hospitals in Jordan between 2017 and 2018. Results: The total shared governance score ranged between 86 and 344 with a mean of 175.6. There were slight differences in the total shared governance scores among the hospitals under study. However, when the sub-scales were compared across the three hospitals, some differences emerged, specifically in nurses' total perceived personnel and total perceived goal and conflict. The median age of the sample members was 28 years and about a half of them (54%) were males. Conclusion: Our results demonstrated that there is a room to increase the level of nurses' control and influence in decision-making, particularly in those departments that scored lower on the index of professional nursing governance. Implications for Nursing: The study results have implications in nursing administration, policy development and decision-making when choosing/adopting a model of organizational SG to cultivate excellence in the workplace. Keywords: Shared governance, Registered nurses, Work environment.

In 2020, the SARS‐COV‐2 disease (COVID‐19) imposed huge challenges on the health, economic, and political systems, and by the end of the year, hope had been born with the release of COVID‐19 vaccines aimed at bringing the pandemic to an end. However, the COVID‐19 vaccination programs have sparked several concerns and ongoing debates over safety issues. Here, we presented three cases of patients with serious adverse events, encephalopathy, vaccine‐induced thrombotic thrombocytopenia, and leukocytoclastic vasculitis, after receiving the ChAdOx1 nCoV‐19 vaccine. Therefore, it is critical to investigate and report the occurrence of adverse reactions following vaccination, particularly serious ones, as it contributes to the growing body of research and assists clinicians in better diagnosing and managing them.